看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。3 }( S0 M6 F8 ^# @' o) B0 g3 W) `
P9 o9 j* K9 H; Q) L$ n w2 }% @
! _! ?1 d& X# J% [* V( |( {- _/ n9 HCurrently available feasibility data for possible combination strategies.
9 o- S; l" D8 ^( s/ L3 Z" S————————————————————————————————0 k+ p7 \+ l1 S6 y" l
Combination Feasibility according to preliminary data
0 w/ p7 f1 O1 K& M! ]1 Y* `: s——————————————————————————————————
, b5 G! f' L' d( e5 I4 t; vBevacizumab + sorafenib Yes, reduced dose # \) r$ p2 N7 b" w8 @
Bevacizumab + sunitinib† No - j2 W9 t/ |2 v
Bevacizumab + temsirolimus Yes 9 o: `7 j; j, | \5 @
Bevacizumab + everolimus Yes " T: v# S' P" a! U0 |
Sorafenib + sunitinib ?
+ k4 I+ b8 ^3 u. NSorafenib + temsirolimus Yes, reduced dose # I }3 z2 U9 d2 W% G ?$ O
Sorafenib + everolimus Yes, reduced dose 6 m9 l5 p& F( V+ ^4 y) h
Sunitinib + temsirolimus† No " n' R/ @# G, T3 @# a, I
Sunitinib + everolimus ?
, v) j9 H8 f8 ~* {3 gTemsirolimus + everolimus ?
4 R3 ?! o. T9 n4 q————————————————————
/ Y1 u* S. i c†Led to US FDA warning.5 j- h1 J# i: V: Z) l% q- [
?: As yet unattempted combination.- y9 j! g% x- H9 P2 B
|